Literature DB >> 1691822

HIV immunization. Fresh pathways to follow.

D P Bolognesi.   

Abstract

Mesh：

Substances：

Year:  1990        PMID： 1691822     DOI： 10.1038/344818a0

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  5 in total

Review 1.  Oral delivery of vaccines. Formulation and clinical pharmacokinetic considerations.

Authors:  D T O'Hagan
Journal:  Clin Pharmacokinet       Date:  1992-01       Impact factor: 6.447

2.  Immunogenicity of influenza and HSV-1 mixed antigen ISCOMs in mice.

Authors:  H O Ghazi; M Erturk; L M Stannard; M Faulkner; C W Potter; R Jennings
Journal:  Arch Virol       Date:  1995       Impact factor: 2.574

3.  Enhancement of human immunodeficiency virus (HIV)-specific CD4+ and CD8+ cytotoxic T-lymphocyte activities in HIV-infected asymptomatic patients given recombinant gp160 vaccine.

Authors:  S K Kundu; D Katzenstein; L E Moses; T C Merigan
Journal:  Proc Natl Acad Sci U S A       Date:  1992-12-01       Impact factor: 11.205

4.  Immunization of mice with baculovirus-derived recombinant SV40 large tumour antigen induces protective tumour immunity to a lethal challenge with SV40-transformed cells.

Authors:  M H Shearer; R K Bright; R E Lanford; R C Kennedy
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

5.  Borna disease virus-infected astrocytes function in vitro as antigen-presenting and target cells for virus-specific CD4-bearing lymphocytes.

Authors:  J A Richt; L Stitz
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.